RESEARCHDIAGNOSTICSTRANSLATIONOUTREACH
 
Rui Bergantim
Name: Rui Bergantim
E-mail: rbergantim@ipatimup.pt
Extension: 
225570700
Academic Degree: PhD, MD


Rui Bergantim
Rui Bergantim
Member of
Temporary of Cancer Drug Resistance


Short CV

Highlights

Supervisor of

PI (running)

PI (closed)
Biomarkers for minimal residual disease
Identifying microRNAs as biomarkers of drug resistance in Multiple Myeloma patients: a pilot project to contribute to guiding personalized therapeutic decisions”
microRNAs as biomarkers of drug response/resistance in multiple myeloma
First Author
 
C
IF
1. Bergantim R, Peixoto da Silva S, Polónia B, Barbosa MAG, Albergaria A, Lima J, Caires HR, Guimarães JE, Vasconcelos MH
Detection of Measurable Residual Disease Biomarkers in Extracellular Vesicles from Liquid Biopsies of Multiple Myeloma Patients-A Proof of Concept. International journal of molecular sciences 23: ., 2022. [Article] 
 doi: 10.3390/ijms232213686 PMID: 36430163.
 
0
6.2 (*)
2. Bergantim R, Bastos J, Soares MJ, Carvalho B, Soares P, Marques C, Costa J, Guimarães JE, Trigo F
Aggressive Central Nervous System Relapse after Autologous Stem Cell Transplant in Multiple Myeloma: Case Reports and Literature Review. Case reports in hematology 2020: 8563098, 2020. [Review] 
 doi: 10.1155/2020/8563098 PMID: 31984141.
 
1
-
Senior Author
 
C
IF
@ 2014 Ipatimup Institute of Molecular Pathology and Immunology of the University of Porto
A
A
A

Send Email
From
To
Subject